The following is a list of selected recently published Expert Opinion articles, related to the content of this issue of Expert Opinion on Emerging Drugs:
Usage of medications with high potential to interact with warfarin among atrial fibrillation residents in long-term care facilities Gregory Reardon, Aarti A Patel, Winnie W Nelson, Tommy Philpot, Marjorie Neidecker Expert Opinion on Pharmacotherapy Feb 2013, Vol. 14, No. 2, Pages 165-173 doi:10.1517/14656566.2013.747509
New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran Vivencio Barrios, Carlos Escobar Expert Opinion on Pharmacotherapy Dec 2012, Vol. 13, No. 18, Pages 2649-2661 doi:10.1517/14656566.2012.749860
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance Teresa Troiani, Silvia Zappavigna, Erika Martinelli, Santolo R. Addeo, Paola Stiuso, Fortunato Ciardiello, Michele Caraglia Expert Opinion on Biological Therapy Feb 2013, Vol. 13, No. 2, Pages 241-255 doi:10.1517/14712598.2012.756469
Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis Petra Dunkel, Christina LL Chai, Beáta Sperlágh, Paul B Huleatt, Péter Mátyus Expert Opinion on Investigational Drugs Sep 2012, Vol. 21, No. 9, Pages 1267-1308 doi:10.1517/13543784.2012.703178
A preliminary evaluation of bardoxolone methyl for the treatment of diabetic nephropathy Merlin Thomas Expert Opinion on Drug Metabolism & Toxicology Aug 2012, Vol. 8, No. 8, Pages 1015-1022 doi:10.1517/17425255.2012.697152
Etoricoxib and the treatment of ankylosing spondylitis Rik J Lories Expert Opinion on Drug Metabolism & Toxicology Dec 2012, Vol. 8, No. 12, Pages 1599-1608 doi:10.1517/17425255.2012.741120
Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma Mohit Kumar Verma, Yasuhiro Miki, Keiko Abe, Hiromichi Niikawa, Hironobu Sasano Expert Opinion on Therapeutic Targets Mar 2012, Vol. 16, No. S1, Pages S91-S102 doi:10.1517/14728222.2011.630664